PharmaPlus teams up with biopharmaceutical companies to complement and enhance their business development activities throughout the deal-making process from partner identification to deal closure.
Already before 2010 we envisioned the enormous market potential of the Asian pharmaceutical market and secured an Asian key strategic partner for a US Nasdaq-listed pharmaceutical company. Our advisory services continue to include securing strategic partners for western companies wishing to access the China market and vice versa.
The right partnering strategy for a product or technology is essential for finding the most suitable partners. PharmaPlus is highly experienced in consulting on partnering …
PharmaPlus works with your company’s scouting team to further increase your accessibility to in-licensing opportunities. Based on your company’s confidential ...
Whatever your reasons, we help you find the right partners for your therapeutics and technologies. At PharmaPlus we use a unique combination ...
Understanding the complexities on how licensing deal negotiations are undertaken can make the difference between failure and success in your regotiations. PharmaPlus …
Company licensing deal valuation
One of the prerequisites of biopharmaceutical licensing negotiations is understanding the possible licensing deal structures available and the financial impact of different deal …